Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

italfarmaco s.p.a. - ferro trivalente, preparati orali - ferro trivalente, preparati orali

Unione Europea - italiano - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - tafasitamab - lymphoma, large b-cell, diffuse - agenti antineoplastici - minjuvi is indicated in combination with lenalidomide followed by minjuvi monotherapy for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) who are not eligible for autologous stem cell transplant (asct).

Unione Europea - italiano - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - ruxolitinib phosphate - vitiligo - altri preparati dermatologici - opzelura is indicated for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

farmaceutica teofarma suisse sa - fluocinonidum, gramicidinum, neomycinum, nystatinum - unguento - fluocinonidum 0.5 mg, gramicidinum 0.25 mg, neomycinum 2.5 mg ut neomycini sulfas, nystatinum 100000 u.i., propyleni carbonas, paraffinum liquidum, alcoholes adipis lanae 5 mg, vaselinum flavum, cera alba, vaselinum album, ad unguentum pro 1 g. - dermatosi superinfettati da batteri e/o lieviti - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

farmaceutica teofarma suisse sa - fluocinonidum, gramicidinum, neomycinum, nystatinum - crema - fluocinonidum 0.5 mg, gramicidinum 0.25 mg, neomycinum 3.5 mg ut neomycini sulfas, nystatinum 100000 u.i., propylenglycolum 150 mg, alcohol cetylicus 40 mg, alcohol stearylicus 70 mg, sorbitani stearas, polysorbatum 60, paraffinum liquidum, acidum citricum, aqua purificata, propylis parahydroxybenzoas 0.5 mg, e 218 1.8 mg, ad unguentum pro 1 g. - dermatosi superinfettati da batteri e/o lieviti - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

almirall ag - fluprednideni-21 acetas, miconazoli nitras - crema - fluprednideni-21 acetas 1 mg, miconazoli nitras 20 mg, propylenglycolum, excipiens annuncio unguento per 1 g. - infiammatoria dermatomykosen - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

moderna switzerland gmbh - davesomeranum, elasomeranum - dispersion for injection - suspension: davesomeranum 0.025 mg pro dosi, elasomeranum 0.025 mg pro dosi, heptadecan-9-ylis 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy)hexyl)amino)-octanoas pro dosi, cholesterolum pro dosi, 1,2-distearoyl-sn-glycero-3-phosphocholinum pro dosi, 1,2-dimyristoyl-rac-glycero-3-polyethylenglycoli 2000 aether methylicus pro dosi, trometamolum pro dosi, trometamoli hydrochloridum pro dosi, acidum aceticum pro dosi, natrii acetas trihydricus pro dosi, saccharum pro dosi, aqua ad iniectabile, pro dosi, natrium 0.017 mg. - omicronspikevax bivalent original / omicron ba.4-5 ist für die aktive immunisierung zur vorbeugung der durch das sars-cov-2-virus verursachten coronavirus-2019-erkrankung (covid-19) bei personen ab 18 jahren indiziert. - vaccini

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

moderna switzerland gmbh - elasomeranum, davesomeranum - siringa preriempita - suspension: elasomeranum 0.025 mg pro dosi, davesomeranum 0.025 mg pro dosi, heptadecan-9-ylis 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy)hexyl)amino)-octanoas pro dosi, cholesterolum pro dosi, 1,2-distearoyl-sn-glycero-3-phosphocholinum pro dosi, 1,2-dimyristoyl-rac-glycero-3-polyethylenglycoli 2000 aether methylicus pro dosi, trometamolum pro dosi, trometamoli hydrochloridum pro dosi, acidum aceticum pro dosi, natrii acetas trihydricus pro dosi, saccharum pro dosi, aqua ad iniectabile pro dosi, pro dosi, natrium 0.017 mg pro dosi. - spikevax bivalent original / omicron ba.4-5 ist für die aktive immunisierung zur vorbeugung der durch das sars-cov-2-virus verursachten coronavirus-2019-erkrankung (covid-19) bei personen ab 18 jahren indiziert. - vaccini

Unione Europea - italiano - EMA (European Medicines Agency)

seqirus gmbh - il virus dell'influenza degli antigeni di superficie (emoagglutinina e neuraminidasi), inattivati) dei seguenti ceppi:a/california/7/2009 (h1n1)pdm09 - ceppo a/brisbane/10/2010, wild type)un/svizzera/9715293/2013 (h3n2) - ceppo(a/south australia/55/2014, wild type)b/phuket/3073/2013–ceppo b/utah/9/2014, wild type) - influenza, human; immunization - vaccini - profilassi dell'influenza per gli adulti, specialmente in quelli che corrono un maggior rischio di complicanze associate. optaflu dovrebbe essere usato in conformità con le linee guida ufficiali.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

armeeapotheke - immunoglobulinum cavalli bitis arietans, immunoglobulinum cavalli bitis gabonica, immunoglobulinum cavalli hemachatus haemachatus, immunoglobulinum cavalli dendroaspis angusticeps, immunoglobulinum cavalli dendroaspis jamesoni, immunoglobulinum cavalli dendroaspis polylepis, immunoglobulinum cavalli naja nivea, immunoglobulinum cavalli naja melanoleuca, immunoglobulinum cavalli naja annulifera, immunoglobulinum cavalli naja mossambica - saimr polivalente serpente antiveleno - lösung: immunoglobulinum equis bitis arietans, immunoglobulinum equis bitis gabonica, immunoglobulinum equis hemachatus haemachatus, immunoglobulinum equis dendroaspis angusticeps, immunoglobulinum equis dendroaspis jamesoni, immunoglobulinum equis dendroaspis polylepis, immunoglobulinum equis naja nivea, immunoglobulinum equis naja melanoleuca, immunoglobulinum equis naja annulifera, immunoglobulinum equis naja mossambica, für alle globuline: dosierung gemäss fi, natrii chloridum, conserv.: metacresolum ≤ 0.35 % m/v, aqua ad iniectabile, q.s. ad solutionem. - antiveleno - antivenine